These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 31449187)

  • 1. A Virtual Crossmatch-based Strategy Facilitates Sharing of Deceased Donor Kidneys for Highly Sensitized Recipients.
    Roll GR; Webber AB; Gae DH; Laszik Z; Tavakol M; Mayen L; Cunniffe K; Syed S; Hirose R; Freise C; Feng S; Roberts JP; Ascher NL; Stock PG; Rajalingam R
    Transplantation; 2020 Jun; 104(6):1239-1245. PubMed ID: 31449187
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Accuracy of virtual crossmatch (VXM) prediction of physical crossmatch (PXM) results of donor specific antibody (DSA) in routine pretransplant settings-a single-center experience.
    Olszowska-Zaremba N; Zagożdżon R; Gozdowska J
    Transpl Immunol; 2022 Jun; 72():101583. PubMed ID: 35314352
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of Physical Crossmatch and Virtual Crossmatch to Identify Preexisting Donor-Specific Human Leukocyte Antigen (HLA) Antibodies and Outcome Following Kidney Transplantation.
    Peng B; Zhuang Q; Yu M; Li J; Liu Y; Zhu L; Ming Y
    Med Sci Monit; 2019 Feb; 25():952-961. PubMed ID: 30712055
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kidney allocation based on proven acceptable antigens results in superior graft survival in highly sensitized patients.
    Heidt S; Haasnoot GW; van Rood JJ; Witvliet MD; Claas FHJ
    Kidney Int; 2018 Feb; 93(2):491-500. PubMed ID: 28947279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A virtual crossmatch protocol significantly increases access of highly sensitized patients to deceased donor kidney transplantation.
    Bingaman AW; Murphey CL; Palma-Vargas J; Wright F
    Transplantation; 2008 Dec; 86(12):1864-8. PubMed ID: 19104435
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Living-Donor Kidney Transplant With Preformed Donor-Specific Antibodies.
    Itabashi Y; Aikawa A; Muramatsu M; Hyoudou Y; Shinoda K; Takahashi Y; Sakurabayashi K; Mizutani T; Oguchi H; Arai T; Kawamura T; Hamasaki Y; Sakai K; Shishido S
    Exp Clin Transplant; 2019 Jan; 17(Suppl 1):43-49. PubMed ID: 30777522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Allocating Deceased Donor Kidneys to Candidates with High Panel-Reactive Antibodies.
    Gebel HM; Kasiske BL; Gustafson SK; Pyke J; Shteyn E; Israni AK; Bray RA; Snyder JJ; Friedewald JJ; Segev DL
    Clin J Am Soc Nephrol; 2016 Mar; 11(3):505-11. PubMed ID: 26839235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. OPO Strategies to Prevent Unintended Use of Kidneys Exported for High PRA (>98% cPRA) Recipients.
    Paramesh AS; Neidlinger N; Salvatore M; Smith A; Friedman A; Payne W; Taber T; Wright C
    Am J Transplant; 2017 Aug; 17(8):2139-2143. PubMed ID: 28168823
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Virtual crossmatch for deceased donor kidney transplantation in the United States: A survey of histocompatibility lab directors and transplant surgeons.
    Puttarajappa CM; Tevar AD; Hoffman W; Degenholtz H; Schinstock CA; Gunabushanam V; Zeevi A; Xu Q; Hariharan S
    Hum Immunol; 2023 Mar; 84(3):214-223. PubMed ID: 36581507
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-HLA Antibody: The Role of Epitopes in Organ Transplantation.
    Argani H
    Exp Clin Transplant; 2019 Jan; 17(Suppl 1):38-42. PubMed ID: 30777521
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of Panel Reactive Antibodies in Renal Transplant Recipients Detected by Luminex: A Single-Center Experience.
    İnal A; Özçelik Ü; Ogan Uyanık E; Külah E; Demirağ A
    Exp Clin Transplant; 2016 Aug; 14(4):401-4. PubMed ID: 26517205
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Virtual HLA Crossmatching as a Means to Safely Expedite Transplantation of Imported Pancreata.
    Eby BC; Redfield RR; Ellis TM; Leverson GE; Schenian AR; Odorico JS
    Transplantation; 2016 May; 100(5):1103-10. PubMed ID: 26950720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum flow cytometric C1q binding antibody analysis of renal recipients with low levels of sensitization.
    Ata P; Canbakan M; Kara M; Özel L; Ünal E; Titiz Mİ
    Transplant Proc; 2012; 44(6):1652-5. PubMed ID: 22841237
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Excellent renal allograft survival in donor-specific antibody positive transplant patients-role of intravenous immunoglobulin and rabbit antithymocyte globulin.
    Mai ML; Ahsan N; Wadei HM; Genco PV; Geiger XJ; Willingham DL; Taner CB; Hewitt WR; Grewal HP; Nguyen JH; Hughes CB; Gonwa TA
    Transplantation; 2009 Jan; 87(2):227-32. PubMed ID: 19155977
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Eplet mismatch analysis and allograft outcome across racially diverse groups in a pediatric transplant cohort: a single-center analysis.
    Philogene MC; Amin A; Zhou S; Charnaya O; Vega R; Desai N; Neu AM; Pruette CS
    Pediatr Nephrol; 2020 Jan; 35(1):83-94. PubMed ID: 31599339
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ten Years of Kidney Paired Donation at Mayo Clinic: The Benefits of Incorporating ABO/HLA Compatible Pairs.
    Basu A; Prieto M; Kosberg C; Mai ML; Khamash HA; Jadlowiec CC; Issa NS; Dean PG; Lorenz EC; Stegall MD; Schinstock CA
    Transplantation; 2020 Jun; 104(6):1229-1238. PubMed ID: 31490859
    [TBL] [Abstract][Full Text] [Related]  

  • 17. One-Year Outcomes of Living Related Kidney Transplant in Patients With Preformed HLA Donor-Specific Antibodies: A Single-Center Experience in Malaysia.
    Jalalonmuhali M; Ng KP; Mohd Shariff NH; Lee YW; Wong AH; Gan CC; Lim SK
    Transplant Proc; 2020; 52(6):1718-1722. PubMed ID: 32448671
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Root cause analysis of limitations of virtual crossmatch for kidney allocation to highly-sensitized patients.
    Jani V; Ingulli E; Mekeel K; Morris GP
    Hum Immunol; 2017 Feb; 78(2):72-79. PubMed ID: 27864154
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modified flow cytometry crossmatch detecting alloantibody-related cytotoxicity as a way to distinguish lytic antibodies from harmless in allosensitised kidney recipients.
    Zieliński M; Zielińska H; Moszkowska G; Dȩbska-Ślizień A; Rutkowski B; Trzonkowski P
    Transplant Proc; 2013; 45(1):88-94. PubMed ID: 23375279
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcomes in the highest panel reactive antibody recipients of deceased donor kidneys under the new kidney allocation system.
    Parajuli S; Redfield RR; Astor BC; Djamali A; Kaufman DB; Mandelbrot DA
    Clin Transplant; 2017 Mar; 31(3):. PubMed ID: 27988992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.